2017 Q2 Form 10-Q Financial Statement

#000112537617000099 Filed on August 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2 2016 Q1
Revenue $448.3M $410.5M $383.2M
YoY Change 9.2% 31.98% 25.02%
Cost Of Revenue $366.9M $330.5M $306.3M
YoY Change 11.01% 23.61% 17.63%
Gross Profit $81.33M $79.98M $76.93M
YoY Change 1.69% 83.02% 66.87%
Gross Profit Margin 18.14% 19.48% 20.07%
Selling, General & Admin $17.30M $19.70M $17.40M
YoY Change -12.18% 28.76% 20.83%
% of Gross Profit 21.27% 24.63% 22.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.75M $9.772M $8.298M
YoY Change 10.01% 53.19% 27.33%
% of Gross Profit 13.22% 12.22% 10.79%
Operating Expenses $28.00M $29.40M $25.70M
YoY Change -4.76% 35.48% 22.38%
Operating Profit $22.03M $19.81M $16.32M
YoY Change 11.22% -9.89% -35.19%
Interest Expense $3.053M $1.446M $1.370M
YoY Change 111.13% 155.03% 105.4%
% of Operating Profit 13.86% 7.3% 8.4%
Other Income/Expense, Net -$2.765M -$1.168M -$1.136M
YoY Change 136.73% 213.98% 126.75%
Pretax Income $19.27M $18.64M $15.18M
YoY Change 3.35% -13.75% -38.48%
Income Tax $6.886M $7.278M $5.889M
% Of Pretax Income 35.74% 39.04% 38.8%
Net Earnings $12.22M $11.33M $9.172M
YoY Change 7.87% -14.12% -39.54%
Net Earnings / Revenue 2.73% 2.76% 2.39%
Basic Earnings Per Share $0.24 $0.23 $0.18
Diluted Earnings Per Share $0.23 $0.22 $0.18
COMMON SHARES
Basic Shares Outstanding 50.71M shares 50.27M shares 50.68M shares
Diluted Shares Outstanding 52.55M shares 51.93M shares 52.33M shares

Balance Sheet

Concept 2017 Q2 2016 Q2 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.10M $37.00M $53.40M
YoY Change 27.3% -33.21% -21.01%
Cash & Equivalents $33.48M $41.57M $33.52M
Short-Term Investments $13.60M $3.500M $2.000M
Other Short-Term Assets $33.50M $24.40M $22.70M
YoY Change 37.3% -16.44% -12.69%
Inventory
Prepaid Expenses
Receivables $243.2M $226.6M $217.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $323.8M $288.0M $293.2M
YoY Change 12.44% 12.53% 14.61%
LONG-TERM ASSETS
Property, Plant & Equipment $490.4M $347.2M $311.5M
YoY Change 41.24% 42.37% 61.92%
Goodwill $73.16M $69.65M $41.03M
YoY Change 5.04% 112.47% 25.18%
Intangibles
YoY Change
Long-Term Investments $25.90M $31.00M $31.00M
YoY Change -16.45% 55.78% 62.3%
Other Assets $13.33M $12.51M $11.17M
YoY Change 6.57% 83.25% 56.7%
Total Long-Term Assets $708.3M $552.1M $480.4M
YoY Change 28.31% 48.01% 51.35%
TOTAL ASSETS
Total Short-Term Assets $323.8M $288.0M $293.2M
Total Long-Term Assets $708.3M $552.1M $480.4M
Total Assets $1.032B $840.1M $773.7M
YoY Change 22.87% 33.57% 34.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.92M $38.09M $35.70M
YoY Change -13.57% 12.53% -8.05%
Accrued Expenses $150.5M $127.2M $117.9M
YoY Change 18.32% 29.4% 25.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $8.165M $634.0K $627.0K
YoY Change 1187.85% 26.55% 459.82%
Total Short-Term Liabilities $204.6M $178.9M $168.1M
YoY Change 14.34% 24.43% 11.78%
LONG-TERM LIABILITIES
Long-Term Debt $284.5M $183.7M $145.6M
YoY Change 54.83% 274.8% 4379.91%
Other Long-Term Liabilities $7.303M $4.778M $4.442M
YoY Change 52.85% 8.79% 20.61%
Total Long-Term Liabilities $291.8M $188.5M $150.1M
YoY Change 54.78% 252.92% 2064.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $204.6M $178.9M $168.1M
Total Long-Term Liabilities $291.8M $188.5M $150.1M
Total Liabilities $561.2M $416.0M $363.5M
YoY Change 34.92% 79.28% 89.71%
SHAREHOLDERS EQUITY
Retained Earnings $244.0M $209.8M $200.6M
YoY Change 16.34% 23.14% 26.07%
Common Stock $258.7M $244.8M $241.1M
YoY Change 5.67% 6.93% 7.13%
Preferred Stock
YoY Change
Treasury Stock (at cost) $38.41M $31.13M $31.22M
YoY Change 23.37% 2305.8% 2294.4%
Treasury Stock Shares 1.932M shares 1.527M shares 1.575M shares
Shareholders Equity $464.3M $423.5M $410.4M
YoY Change
Total Liabilities & Shareholders Equity $1.032B $840.1M $773.7M
YoY Change 22.87% 33.57% 34.95%

Cashflow Statement

Concept 2017 Q2 2016 Q2 2016 Q1
OPERATING ACTIVITIES
Net Income $12.22M $11.33M $9.172M
YoY Change 7.87% -14.12% -39.54%
Depreciation, Depletion And Amortization $10.75M $9.772M $8.298M
YoY Change 10.01% 53.19% 27.33%
Cash From Operating Activities $5.300M $24.10M $12.70M
YoY Change -78.01% 2577.78% 116.64%
INVESTING ACTIVITIES
Capital Expenditures -$11.00M -$19.00M $18.23M
YoY Change -42.11% -40.44% 43.34%
Acquisitions $490.0K
YoY Change -98.73%
Other Investing Activities -$16.20M -$60.70M -$1.900M
YoY Change -73.31% 187.68% -91.98%
Cash From Investing Activities -$27.20M -$79.80M -$20.10M
YoY Change -65.91% 50.85% -44.85%
FINANCING ACTIVITIES
Cash Dividend Paid $2.072M
YoY Change 21.31%
Common Stock Issuance & Retirement, Net $30.00M
YoY Change -126.77%
Debt Paid & Issued, Net $110.2M
YoY Change 17.15%
Cash From Financing Activities 23.90M 37.80M $17.21M
YoY Change -36.77% -5.5% -59.79%
NET CHANGE
Cash From Operating Activities 5.300M 24.10M $12.70M
Cash From Investing Activities -27.20M -79.80M -$20.10M
Cash From Financing Activities 23.90M 37.80M $17.21M
Net Change In Cash 2.000M -17.90M $9.801M
YoY Change -111.17% 49.17% -19.67%
FREE CASH FLOW
Cash From Operating Activities $5.300M $24.10M $12.70M
Capital Expenditures -$11.00M -$19.00M $18.23M
Free Cash Flow $16.30M $43.10M -$5.536M
YoY Change -62.18% 31.4% -19.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001125376
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50868326 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ENSIGN GROUP, INC
CY2017Q2 ensg Assistedand Independent Living Facilities
AssistedandIndependentLivingFacilities
46 facilities
ensg Average Non Cancellable Equipment Lease Maximum Term
AverageNonCancellableEquipmentLeaseMaximumTerm
P5Y0M
ensg Average Non Cancellable Equipment Leases Minimum Term
AverageNonCancellableEquipmentLeasesMinimumTerm
P3Y0M
ensg Average Operating Lease Maximum Term
AverageOperatingLeaseMaximumTerm
P20Y0M
ensg Average Operating Lease Minimum Term
AverageOperatingLeaseMinimumTerm
P5Y0M
CY2016Q4 ensg Cash Held In Trust For Residents
CashHeldInTrustForResidents
2373000 USD
CY2017Q2 ensg Cash Held In Trust For Residents
CashHeldInTrustForResidents
2460000 USD
CY2016Q4 ensg Deferred Rent And Other Long Term Liabilities
DeferredRentAndOtherLongTermLiabilities
9124000 USD
CY2017Q2 ensg Deferred Rent And Other Long Term Liabilities
DeferredRentAndOtherLongTermLiabilities
11119000 USD
ensg Deferredtaxexpenseincludingexcesstaxdeficienciesfrom Sharebased Compensation
DeferredtaxexpenseincludingexcesstaxdeficienciesfromSharebasedCompensation
3000 USD
ensg Deferredtaxexpenseincludingexcesstaxdeficienciesfrom Sharebased Compensation
DeferredtaxexpenseincludingexcesstaxdeficienciesfromSharebasedCompensation
61000 USD
ensg Depreciation And Amortization Including Discontinued Operations
DepreciationAndAmortizationIncludingDiscontinuedOperations
18069000 USD
ensg Depreciation And Amortization Including Discontinued Operations
DepreciationAndAmortizationIncludingDiscontinuedOperations
21264000 USD
ensg Escrow Deposits Used To Fund Business Acquisitions
EscrowDepositsUsedToFundBusinessAcquisitions
400000 USD
ensg Escrow Deposits Used To Fund Business Acquisitions
EscrowDepositsUsedToFundBusinessAcquisitions
1582000 USD
CY2017Q2 ensg Facilities Under Master Lease Arrangement
FacilitiesUnderMasterLeaseArrangement
25 facilities
ensg Facilitiesunder Medicare Probe Reviews
FacilitiesunderMedicareProbeReviews
5 facilities
CY2017Q2 ensg Home Health Hospiceand Home Care Operations
HomeHealthHospiceandHomeCareOperations
41 business
ensg Increase Decrease In Insurance Subsidiary Deposits And Investments
IncreaseDecreaseInInsuranceSubsidiaryDepositsAndInvestments
196000 USD
ensg Increase Decrease In Insurance Subsidiary Deposits And Investments
IncreaseDecreaseInInsuranceSubsidiaryDepositsAndInvestments
-4358000 USD
CY2016Q4 ensg Insurance Subsidiary Deposits And Investments
InsuranceSubsidiaryDepositsAndInvestments
23634000 USD
CY2017Q2 ensg Insurance Subsidiary Deposits And Investments
InsuranceSubsidiaryDepositsAndInvestments
25899000 USD
CY2016Q2 ensg Intersegmentrevenue
Intersegmentrevenue
0 USD
ensg Intersegmentrevenue
Intersegmentrevenue
0 USD
CY2017Q2 ensg Intersegmentrevenue
Intersegmentrevenue
0 USD
ensg Intersegmentrevenue
Intersegmentrevenue
0 USD
CY2013 ensg Litigation Settlement Paidto U.S.Government
LitigationSettlementPaidtoU.S.Government
48000000 USD
ensg Litigation Settlement Tax Benefit
LitigationSettlementTaxBenefit
0 USD
ensg Litigation Settlement Tax Benefit
LitigationSettlementTaxBenefit
4220000 USD
CY2016Q4 ensg Long Term Debt Net Of Current Maturities And Debt Discount
LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount
275486000 USD
CY2017Q2 ensg Long Term Debt Net Of Current Maturities And Debt Discount
LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount
284465000 USD
ensg Losses Relatedto Class Action Settlement
LossesRelatedtoClassActionSettlement
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
137000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
111000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
2715000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-524000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
4097000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1385000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
ensg Losses Relatedto Class Action Settlement
LossesRelatedtoClassActionSettlement
11000000 USD
ensg Lossesrelatedtooperationalclosurenetoffixedassetimpairment
Lossesrelatedtooperationalclosurenetoffixedassetimpairment
7558000 USD
ensg Lossesrelatedtooperationalclosurenetoffixedassetimpairment
Lossesrelatedtooperationalclosurenetoffixedassetimpairment
2620000 USD
CY2017Q2 ensg Master Leaseagreements
MasterLeaseagreements
6 facilities
CY2016Q4 ensg Number Of Real Estate Properties Leased
NumberOfRealEstatePropertiesLeased
160 facilities
CY2017Q2 ensg Number Of Real Estate Properties Leased
NumberOfRealEstatePropertiesLeased
166 facilities
CY2016Q4 ensg Number Of Real Estate Properties Leased With Option To Purchase
NumberOfRealEstatePropertiesLeasedWithOptionToPurchase
9 facilities
CY2017Q2 ensg Number Of Real Estate Properties Leased With Option To Purchase
NumberOfRealEstatePropertiesLeasedWithOptionToPurchase
10 facilities
CY2016Q4 ensg Number Of Real Estate Properties Operated
NumberOfRealEstatePropertiesOperated
210 facilities
CY2017Q2 ensg Number Of Real Estate Properties Operated
NumberOfRealEstatePropertiesOperated
222 facilities
CY2017Q2 ensg Numberof Option Plans
NumberofOptionPlans
4 Agreements
CY2015Q4 ensg Numberof Stock Repurchase Programs
NumberofStockRepurchasePrograms
2 Agreements
CY2017Q2 ensg Operational Assisted Living Units
OperationalAssistedLivingUnits
4700 Beds
CY2017Q2 ensg Operational Skilled Nursing Beds
OperationalSkilledNursingBeds
18400 Beds
ensg Payments To Acquire Leased Assets
PaymentsToAcquireLeasedAssets
777000 USD
ensg Payments To Acquire Leased Assets
PaymentsToAcquireLeasedAssets
310000 USD
CY2016Q4 ensg Quality Assurance Fee
QualityAssuranceFee
4604000 USD
CY2017Q2 ensg Quality Assurance Fee
QualityAssuranceFee
6989000 USD
CY2016Q4 ensg Resident Deposits
ResidentDeposits
6099000 USD
CY2017Q2 ensg Resident Deposits
ResidentDeposits
6210000 USD
CY2016Q4 ensg Resident Refunds Payable
ResidentRefundsPayable
18368000 USD
CY2017Q2 ensg Resident Refunds Payable
ResidentRefundsPayable
20015000 USD
ensg Restricted Awards Grant Date Fair Value Range Maximum
RestrictedAwardsGrantDateFairValueRangeMaximum
23.23
ensg Restricted Awards Grant Date Fair Value Range Maximum
RestrictedAwardsGrantDateFairValueRangeMaximum
20.68
ensg Restricted Awards Grant Date Fair Value Range Minimum
RestrictedAwardsGrantDateFairValueRangeMinimum
19.58
ensg Restricted Awards Grant Date Fair Value Range Minimum
RestrictedAwardsGrantDateFairValueRangeMinimum
18.47
CY2016Q2 ensg Revenue By Payor As Percent Of Total Revenue
RevenueByPayorAsPercentOfTotalRevenue
1.000 Rate
ensg Revenue By Payor As Percent Of Total Revenue
RevenueByPayorAsPercentOfTotalRevenue
1.000 Rate
CY2017Q2 ensg Revenue By Payor As Percent Of Total Revenue
RevenueByPayorAsPercentOfTotalRevenue
1.000 Rate
ensg Revenue By Payor As Percent Of Total Revenue
RevenueByPayorAsPercentOfTotalRevenue
1.000 Rate
CY2016Q2 ensg Revenueincludingintersegmentrevenue
Revenueincludingintersegmentrevenue
410517000 USD
ensg Revenueincludingintersegmentrevenue
Revenueincludingintersegmentrevenue
793750000 USD
CY2017Q2 ensg Revenueincludingintersegmentrevenue
Revenueincludingintersegmentrevenue
448279000 USD
ensg Revenueincludingintersegmentrevenue
Revenueincludingintersegmentrevenue
890019000 USD
CY2016Q4 ensg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
2704000 shares
CY2017Q2 ensg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
2957000 shares
ensg Share Based Compensation Restricted Awards Exercise Price
ShareBasedCompensationRestrictedAwardsExercisePrice
0 USD
CY2017Q2 ensg Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Fair Value
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue
26279000 USD
CY2017Q2 ensg Transitionaland Skilled Service Facilities
TransitionalandSkilledServiceFacilities
155 facilities
CY2017Q2 ensg Transitionaland Skilled Servicesand Assistantand Independent Living Campuses
TransitionalandSkilledServicesandAssistantandIndependentLivingCampuses
21 facilities
CY2016Q2 ensg Weighted Average Dividend Yield
WeightedAverageDividendYield
0.0079 Rate
ensg Weighted Average Dividend Yield
WeightedAverageDividendYield
0.0078 Rate
CY2017Q2 ensg Weighted Average Dividend Yield
WeightedAverageDividendYield
0.0089 Rate
ensg Weighted Average Dividend Yield
WeightedAverageDividendYield
0.0084 Rate
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
38991000 USD
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
32915000 USD
CY2016Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
284224000 USD
CY2017Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
283007000 USD
CY2016Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
244433000 USD
CY2017Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
243248000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
244433000 USD
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
243248000 USD
CY2016Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
9130000 USD
CY2017Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
8058000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110036000 USD
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
126763000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
252493000 USD
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
258632000 USD
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2137000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4022000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2039000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3930000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
39791000 USD
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
39759000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
313000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
509000 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1410000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2497000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
690000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1302000 USD
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
850000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
774000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1312000 shares
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1378000 shares
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-268000 USD
CY2016Q4 us-gaap Assets
Assets
1001025000 USD
CY2017Q2 us-gaap Assets
Assets
1032184000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
333862000 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
323845000 USD
CY2016Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
6000 USD
CY2017Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
326000 USD
CY2016Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
0 USD
us-gaap Business Exit Costs1
BusinessExitCosts1
7935000 USD
CY2017Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
-1286000 USD
us-gaap Business Exit Costs1
BusinessExitCosts1
2731000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5682000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5130000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41569000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33519000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57706000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33476000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8050000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24230000 USD
CY2017Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0400
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0800
CY2017Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0425
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0850
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52787000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53173000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50838000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50795000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
52000 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
53000 USD
CY2016Q2 us-gaap Cost Of Services
CostOfServices
330538000 USD
us-gaap Cost Of Services
CostOfServices
636846000 USD
CY2017Q2 us-gaap Cost Of Services
CostOfServices
366946000 USD
us-gaap Cost Of Services
CostOfServices
722433000 USD
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
390708000 USD
us-gaap Costs And Expenses
CostsAndExpenses
757627000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
426248000 USD
us-gaap Costs And Expenses
CostsAndExpenses
860436000 USD
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
284157000 USD
CY2017Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
293106000 USD
CY2016Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2016Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3611000 USD
CY2017Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3169000 USD
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
6994000 USD
CY2017Q2 us-gaap Deferred Revenue
DeferredRevenue
4608000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
23073000 USD
CY2017Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
23013000 USD
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1582000 USD
CY2017Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
23925000 USD
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9772000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18069000 USD
CY2017Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10750000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21264000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
3065000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
1049000 USD
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2186000 USD
CY2017Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2182000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
84686000 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
72701000 USD
CY2016Q4 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
4104000 USD
CY2017Q2 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
4662000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1561000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1534000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8086000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9388000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
21359000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2321000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1388000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2244000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2301000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2270000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2301000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
43162000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
43572000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35076000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34184000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6512000 USD
CY2017Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-11000000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19657000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37045000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17253000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38523000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
67100000 USD
CY2017Q2 us-gaap Goodwill
Goodwill
73159000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
6059000 USD
CY2016Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
410517000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
793750000 USD
CY2017Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
448279000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
890019000 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
137000 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
111000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18641000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33820000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19266000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23663000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
11363000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
20653000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
12380000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
15337000 USD
CY2017Q2 us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
697000 USD
us-gaap Income Tax Effects Allocated Directly To Equity Employee Stock Options
IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions
1207000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7278000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13167000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6886000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8326000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
11552000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
19543000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
545000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4379000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29295000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14289000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-195000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1182000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-6871000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11985000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
127000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
321000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
623000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
332000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
760000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1550000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2337000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4533000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
10041000 USD
us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
6814000 USD
us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
3759000 USD
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
19586000 USD
CY2017Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
24444000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
1446000 USD
us-gaap Interest Expense
InterestExpense
2816000 USD
CY2017Q2 us-gaap Interest Expense
InterestExpense
3053000 USD
us-gaap Interest Expense
InterestExpense
6498000 USD
us-gaap Interest Paid
InterestPaid
2699000 USD
us-gaap Interest Paid
InterestPaid
7160000 USD
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
278000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
513000 USD
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
288000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
578000 USD
CY2016Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
30916000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
58051000 USD
CY2017Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
32851000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
64843000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
540530000 USD
CY2017Q2 us-gaap Liabilities
Liabilities
561223000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1001025000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1032184000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
211928000 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
204578000 USD
CY2016Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 USD
CY2017Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
11000000 USD
us-gaap Litigation Settlement Amount
LitigationSettlementAmount
0 USD
us-gaap Litigation Settlement Amount
LitigationSettlementAmount
11000000 USD
CY2016Q4 us-gaap Loans Receivable Net
LoansReceivableNet
700000 USD
CY2017Q2 us-gaap Loans Receivable Net
LoansReceivableNet
0 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8129000 USD
CY2017Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
8165000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
275486000 USD
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
284465000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
4046000 USD
CY2017Q2 us-gaap Minority Interest
MinorityInterest
6632000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54979000 USD
CY2017Q2 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
13329000 USD
us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
6704000 USD
us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
23925000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7288000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99857000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48626000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36828000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24920000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
11326000 USD
us-gaap Net Income Loss
NetIncomeLoss
20498000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
12217000 USD
us-gaap Net Income Loss
NetIncomeLoss
15058000 USD
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
37000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
155000 USD
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
163000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
279000 USD
CY2016Q4 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
50 facilities
CY2017Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
56 facilities
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segments
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
19809000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
36123000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22031000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
29583000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1731717000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
132331000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
128449000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
130408000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
131149000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
131633000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
994990000 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
82757000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
58763000 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
58787000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12614000 USD
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13329000 USD
CY2016Q2 us-gaap Other Cost Of Services
OtherCostOfServices
30741000 USD
us-gaap Other Cost Of Services
OtherCostOfServices
57732000 USD
CY2017Q2 us-gaap Other Cost Of Services
OtherCostOfServices
32585000 USD
us-gaap Other Cost Of Services
OtherCostOfServices
64485000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58763000 USD
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58787000 USD
CY2016Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
1972000 USD
CY2017Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
962000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5855000 USD
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7303000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1168000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2303000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2765000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5920000 USD
CY2016Q4 us-gaap Other Restricted Assets
OtherRestrictedAssets
673000 USD
CY2017Q2 us-gaap Other Restricted Assets
OtherRestrictedAssets
790000 USD
CY2016Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
12614000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
4350000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
56292000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
41763000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
56081000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
41645000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
310000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36443000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23013000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
83000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19871000 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23135000 USD
CY2016Q4 us-gaap Prepaid Taxes
PrepaidTaxes
302000 USD
CY2017Q2 us-gaap Prepaid Taxes
PrepaidTaxes
10343000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
332000000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
460000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
371000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1017000 USD
us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
92000 USD
us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4124000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2249000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
11363000 USD
us-gaap Profit Loss
ProfitLoss
20653000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
12380000 USD
us-gaap Profit Loss
ProfitLoss
15337000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
594534000 USD
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
617149000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
484498000 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
490386000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12081000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14647000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
247316000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
451052000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
235021000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
244049000 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
0 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
92000 USD
CY2017Q2 us-gaap Sale Leaseback Transaction Deferred Gain Gross
SaleLeasebackTransactionDeferredGainGross
13153000 USD
CY2016Q4 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
0 USD
CY2017Q2 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
12403000 USD
CY2017Q2 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
38000000 USD
CY2017Q2 us-gaap Sale Leaseback Transaction Historical Cost
SaleLeasebackTransactionHistoricalCost
24847000 USD
CY2017Q2 us-gaap Sale Leaseback Transaction Lease Terms
SaleLeasebackTransactionLeaseTerms
20
us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
0 USD
us-gaap Sale Leaseback Transaction Net Proceeds Investing Activities
SaleLeasebackTransactionNetProceedsInvestingActivities
38000000 USD
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
410517000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.55
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
793750000 USD
CY2017Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
448279000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
890019000 USD
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
3526000 USD
CY2017Q2 us-gaap Security Deposit
SecurityDeposit
4708000 USD
CY2016Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
21359000 USD
CY2017Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
21010000 USD
CY2016Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
43992000 USD
CY2017Q2 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
48658000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4665000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4600000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y0M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
18.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
19.40
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
429000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
446000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.42
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
75000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
18.79
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0149 Rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0140 Rate
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0190 Rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0196 Rate
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.411 Rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.392 Rate
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.358 Rate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.358 Rate
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6662000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.18
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.17
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
103000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.50
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
121000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
288000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
124000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
280000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.84
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5176000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5058000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.62
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.28
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.13
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.76
CY2017Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2957000 shares
CY2017Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
5058000 shares
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M35D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M35D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M35D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M35D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M40D
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
11550000 USD
CY2017Q2 us-gaap Short Term Investments
ShortTermInvestments
13643000 USD
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
7000 shares
CY2016Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
52000 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
214000 shares
CY2017Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
46000 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
99000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
295000 shares
CY2017Q1 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2018-02-08
CY2015Q4 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P0Y12M
CY2017Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P0Y12M
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
456449000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
464329000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
460495000 USD
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
470961000 USD
CY2016Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1182000 USD
CY2017Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
0 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1520000 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1932000 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31117000 USD
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
38405000 USD
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51931000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52134000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52548000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52593000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50274000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50476000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50705000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50736000 shares
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
197000 USD
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Estimates and Assumptions &#8212;</font><font style="font-family:inherit;font-size:10pt;"> The preparation of Interim Financial Statements in conformity with GAAP&#160;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company&#8217;s Interim Financial Statements relate to revenue, allowance for doubtful accounts, intangible assets and goodwill, impairment of long-lived assets, general and professional liability, workers' compensation and healthcare claims included in accrued self-insurance liabilities, and income taxes. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001125376-17-000099-index-headers.html Edgar Link pending
0001125376-17-000099-index.html Edgar Link pending
0001125376-17-000099.txt Edgar Link pending
0001125376-17-000099-xbrl.zip Edgar Link pending
ensg-20170630.xml Edgar Link completed
ensg-20170630.xsd Edgar Link pending
ensg-20170630_cal.xml Edgar Link unprocessable
ensg-20170630_def.xml Edgar Link unprocessable
ensg-20170630_lab.xml Edgar Link unprocessable
ensg-20170630_pre.xml Edgar Link unprocessable
ensg0630201710q.htm Edgar Link pending
ensg63017ex321.htm Edgar Link pending
ensg6302017ex322.htm Edgar Link pending
ensgq22017ex311.htm Edgar Link pending
ensgq22017ex312.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending